Abstract
To assess and compare refractive error and smoking habits in patients with exudative age-related macular degeneration (AMD) in a clinical setting. The clinical comparative study included 379 patients (379 eyes) who underwent intravitreal application of an anti-vascular growth factor drug for the treatment of exudative AMD, and 191 patients without exudative macular degeneration and who underwent surgery for age-related cataract. Smoking status was compared with an age-matched control group of the German population described in the census of 2003. The main outcome measures were refractive error, axial length, and data from a questionnaire on smoking habits. The AMD group compared with the cataract group showed a significantly shorter axial length (23.31±0.75 vs 24.20±1.56 mm; Pvs −1.71±4.57 dioptres; PP75 years, current smokers: 6.3% vs 6.4% (P=0.97); former smokers: 19.7% vs 22.8% (P=0.25)). In our setting, an association was found between short axial length and AMD. We were not able to confirm the previously reported link between smoking and AMD.

This publication has 20 references indexed in Scilit: